ORIGINAL PAPER
Patterns and prevalence of psychiatric morbidity
among individuals with rheumatoid arthritis
1
Centre for Rheumatic Diseases, Shifa Superspeciality Hospital, Srinagar, India
2
Government Medical College, Srinagar, India
3
Department of Rheumatology, Max Super Speciality Hospital, New Delhi, India
4
Shifa Superspeciality Hospital, Magarmal Bagh, Srinagar, India
Submission date: 2024-01-26
Final revision date: 2024-04-05
Acceptance date: 2024-04-09
Online publication date: 2024-04-30
Corresponding author
Reumatologia 2024;62(2):115-120
KEYWORDS
rheumatoid arthritispsychiatric comorbiditiesmajor depressive disordersomatoform disordergeneralized anxiety disorder
TOPICS
ABSTRACT
Objectives:
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that affects the joints, causing inflammation, pain, and potential joint damage. Patients with RA are at high risk of developing psychiatric morbidity; it is important to recognize these psychiatric manifestations. The relationship between psychiatric symptoms and RA is complex and can involve various factors, including the impact of chronic pain, inflammation, medications, and the overall burden of managing a chronic illness. Aim of the study was to systematically investigate and analyze the patterns and prevalence of psychiatric morbidity among individuals diagnosed with RA, with the aim of identifying common mental health conditions, understanding the interplay between RA and psychiatric disorders, and providing valuable insights for improved holistic patient care.
Material and methods:
This was a prospective, observational cross-sectional study conducted over a period of three years in patients with RA. Psychiatric morbidity was assessed using International Classification of Diseases-10 criteria and Mini-Plus by dedicated psychiatrists. The diagnosis of RA was confirmed using the 2010 American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR) diagnostic criteria for RA and the disease activity was calculated by Disease Activity Score with 28-joint count (DAS28) using the calculator from the RheumaHelper application. The data were analyzed using SPSS, version 23.0.
Results:
A total of 1,000 patients with RA were included in this study. Nearly two-thirds of the patients were female (64.8%). The majority of patients belonged to the age group of 41 to 54 years. Total 47.5% of the patients were unemployed, 27.0% were salaried, 19.0% were businessman, while 6.5% of the patients were students. More than half of the patients (53.2%) had moderate disease activity. Major depressive disorder was the most commonly observed comorbidity (41.0%), followed by somatoform disorder (28.5%), and generalized anxiety disorder was found in 13.5%. No psychiatric manifestations were found in 17% of studied individuals.
Conclusions:
Psychiatric morbidity is associated with RA and there is a need for psychiatric services to be made available to these patients.
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that affects the joints, causing inflammation, pain, and potential joint damage. Patients with RA are at high risk of developing psychiatric morbidity; it is important to recognize these psychiatric manifestations. The relationship between psychiatric symptoms and RA is complex and can involve various factors, including the impact of chronic pain, inflammation, medications, and the overall burden of managing a chronic illness. Aim of the study was to systematically investigate and analyze the patterns and prevalence of psychiatric morbidity among individuals diagnosed with RA, with the aim of identifying common mental health conditions, understanding the interplay between RA and psychiatric disorders, and providing valuable insights for improved holistic patient care.
Material and methods:
This was a prospective, observational cross-sectional study conducted over a period of three years in patients with RA. Psychiatric morbidity was assessed using International Classification of Diseases-10 criteria and Mini-Plus by dedicated psychiatrists. The diagnosis of RA was confirmed using the 2010 American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR) diagnostic criteria for RA and the disease activity was calculated by Disease Activity Score with 28-joint count (DAS28) using the calculator from the RheumaHelper application. The data were analyzed using SPSS, version 23.0.
Results:
A total of 1,000 patients with RA were included in this study. Nearly two-thirds of the patients were female (64.8%). The majority of patients belonged to the age group of 41 to 54 years. Total 47.5% of the patients were unemployed, 27.0% were salaried, 19.0% were businessman, while 6.5% of the patients were students. More than half of the patients (53.2%) had moderate disease activity. Major depressive disorder was the most commonly observed comorbidity (41.0%), followed by somatoform disorder (28.5%), and generalized anxiety disorder was found in 13.5%. No psychiatric manifestations were found in 17% of studied individuals.
Conclusions:
Psychiatric morbidity is associated with RA and there is a need for psychiatric services to be made available to these patients.
REFERENCES (35)
1.
Benitha R, Tikly M. Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 2007; 26: 24–29, DOI: 10.1007/s10067-006-0215-4.
2.
Dickens C, Creed F. The burden of depression in patients with rheumatoid arthritis. Rheumatology (Oxford) 2001; 40: 1327–1330, DOI: 10.1093/rheumatology/40.12.1327.
3.
Dickens C, Jackson J, Tomenson B, et al. Association of depression and rheumatoid arthritis. Psychosomatics 2003; 44: 209–215, DOI: 10.1176/appi.psy.44.3.209.
4.
Gettings L. Psychological well-being in rheumatoid arthritis: a review of the literature. Musculoskeletal Care 2010; 8: 99–106, DOI: 10.1002/msc.171.
5.
Fifield J, Tennen H, Reisine S, McQuillan J. Depression and the long-term risk of pain, fatigue, and disability in patients with rheumatoid arthritis. Arthritis Rheum 1998; 41: 1851–1857, DOI: 10.1002/1529-0131(199810)41: 10<1851: : AID-ART18>3.0.CO; 2-I.
6.
Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 2013; 52: 2136–2148, DOI: 10.1093/rheumatology/ket169.
7.
Sambamoorthi U, Shah D, Zhao X. Healthcare burden of de- pression in adults with arthritis. Expert Rev Pharmacoecon Outcomes Res 2017; 17: 53–65, DOI: 10.1080/14737167.2017. 1281744.
8.
Margaretten M, Julian L, Katz P, Yelin E. Depression in patients with rheumatoid arthritis: description, causes and mecha- nisms. Int J Clin Rheumtol 2011; 6: 617–623, DOI: 10.2217/IJR.11.6.
9.
Graves H, Scott DL, Lempp H, Weinman J. Illness beliefs predict disability in rheumatoid arthritis. J Psychosom Res 2009; 67: 417–423, DOI: 10.1016/j.jpsychores.2009.01.006.
10.
Murphy S, Creed F, Jayson MI. Psychiatric disorder and illness behaviour in rheumatoid arthritis. Br J Rheumatol 1988; 27: 357–363, DOI: 10.1093/rheumatology/27.5.357.
11.
Bekhuis E, Boschloo L, Rosmalen JG, Schoevers RA. Differential associations of specific depressive and anxiety disorders with somatic symptoms. J Psychosom Res 2015; 78: 116–122, DOI: 10.1016/j.jpsychores.2014.11.007.
12.
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569–2581, DOI: 10.1002/art.27584.
13.
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324, DOI: 10.1002/art.1780310302.
14.
Anderson J, Caplan L, Yazdany J, et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 2012; 64: 640–647, DOI: 10.1002/acr.21649.
15.
Gururaj M. Kuppuswamy’s socio-economic status scale: a revision of income parameter for 2014. Int J Recent Trends Sci Technol 2014; 11: 1–2, DOI: 10.1007/s12098-016-2223-y.
16.
Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 Suppl 20: 22–57.
17.
Husain MI, Chaudhry N, Morris J, et al. Psychosocial correlates, psychological distress, and quality of life in patients with medically unexplained symptoms: a primary care study in Karachi, Pakistan. Int J Psychiatry Med 2015; 48: 235–251, DOI: 10.2190/PM.48.4.a.
18.
Intriago M, Maldonado G, Cárdenas J, Ríos C. Clinical characteristics in patients with rheumatoid arthritis: Differences between Genders. ScientificWorldJournal 2019; 2019: 8103812, DOI: 10.1155/2019/8103812.
19.
Lin YJ, Anzaghe M, Schülke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells 2020; 9: 880, DOI: 10.3390/cells9040880.
20.
Siddiqui F, Kumar A. A study of the factors associated with anxiety and depression among the patients of arthritis. IJRR 2017; 5: 872–876, DOI: 10.17511/ijmrr.2017.i09.07.
21.
Imran MY, Saira Khan EA, Ahmad NM, et al. Depression in rheumatoid arthritis and its relation to disease activity. Pak J Med Sci 2015; 31: 393–397, DOI: 10.12669/pjms.312.6589.
22.
Safiri S, Kolahi AA, Hoy D, et al. Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017. Ann Rheum Dis 2019; 78: 1463–1471, DOI: 10.1136/annrheumdis- 2019-215920.
23.
Mukherjee D, Lahiry S, Sinha R. Association of depression in rheumatoid arthritis: a single centre experience. Int J Res Med Sci 2017; 5: 3600–3604, DOI: 10.18203/2320-6012.IJRMS20173570.
24.
Bergstra SA, Allaart CF, Ramiro S, et al. Sex-associated treatment differences and their outcomes in rheumatoid arthritis: Results from the METEOR Register. J Rheumatol 2018; 45: 1361–1366, DOI: 10.3899/jrheum.171176.
25.
Fakra E, Marotte H. Rheumatoid arthritis and depression. Joint Bone Spine 2021; 88: 105200, DOI: 10.1016/ j.jbspin.2021.105200.
26.
Lard LR, Visser H, Speyer I, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001; 111: 446–451, DOI: 10.1016/ s0002-9343(01)00872-5.
27.
Deb A, Dwibedi N, LeMasters T, et al. Burden of depression among working-age adults with rheumatoid arthritis. Arthritis 2018; 2018: 8463632, DOI: 10.1155/2018/8463632.
28.
Arvind BA, Gururaj G, Loganathan S, et al. Prevalence and socioeconomic impact of depressive disorders in India: multisite population-based cross-sectional study. BMJ Open 2019; 9: e027250, DOI: 10.1136/bmjopen-2018-027250.
29.
Mandal M, Dasgupta A, Dutt D, et al. Quantification of health-related quality of life among patients with rheumatoid arthritis: An institution-based study in Kolkata, West Bengal. J Family Med Prim Care 2020; 9: 3970–3976, DOI: 10.4103/jfmpc.jfmpc_53_20.
30.
Sunar S, Garip Y, Yilmaz O, et al. Disease activity (Rheumatoid Arthritis Disease Activity Index-5) in patients with rheumatoid arthritis and its association with quality of life, pain, fatigue, and functional and psychological status. Rheumatology 2015; 30: 144–149.
31.
Vallerand IA, Lewinson RT, Frolkis AD, et al. Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study. RMD Open 2018; 4: e000670, DOI: 10.1136/rmdopen-2018-000670.
32.
Sautner J, Puchner R, Alkin A, Pieringer H. Depression: a common comorbidity in women with rheumatoid arthritis-results from an Austrian cross-sectional study. BMJ Open 2020; 10: e033958, DOI: 10.1136/bmjopen-2019-033958.
33.
Hassan AA, Nasr MH, Mohamed AL, et al. Psychological affection in rheumatoid arthritis patients in relation to disease activity [published correction appears in Medicine (Baltimore) 2019; 98: e16515]. Medicine (Baltimore) 2019; 98: e15373, DOI: 10.1097/MD.0000000000015373.
34.
Covic T, Cumming SR, Pallant JF, et al. Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry 2012; 12: 6, DOI: 10.1186/1471-244X-12-6.
35.
Matcham F, Ali S, Irving K, et al. Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study. BMC Musculoskelet Disord 2016; 17: 155, DOI: 10.1186/s12891-016-1011-1.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
